Publication:
The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict new cardiovascular events in essential hypertensive patients

Placeholder

Organizational Units

Program

KU Authors

Co-Authors

Turak, Osman
Afsar, Baris
Ozcan, Firat
Oksuz, Fatih
Mendi, Mehmet Ali
Yayla, Cagri
Covic, Adrian

Advisor

Publication Date

2016

Language

English

Type

Journal Article

Journal Title

Journal ISSN

Volume Title

Abstract

Triglyceride (TG) to high-density lipoprotein cholesterol (HDL-C) ratio (TG/HDL-C) has been suggested as a simple method to identify unfavorable cardiovascular outcomes in the general population. The effect of the TG/HDL-C ratio on essential hypertensive patients is unclear. About 900 consecutive essential hypertensive patients (mean age 52.9 +/- 12.6 years, 54.2% male) who visited our outpatient hypertension clinic were analyzed. Participants were divided into quartiles based on baseline TG/HDL-C ratio and medical records were obtained periodically for the occurrence of fatal events and composite major adverse cardiovascular events (MACEs) including transient ischemic attack, stroke, aortic dissection, acute coronary syndrome, and death. Participants were followed for a median of 40 months (interquartile range, 35-44 months). Overall, a higher quartile of TG/HDL-C ratio at baseline was significantly linked with higher incidence of fatal and nonfatal cardiovascular events. Using multivariate Cox regression analysis, plasma TG/HDL-C ratio was independently associated with increased risk of fatal events (hazard ratio [HR], 1.25; 95% confidence interval [CI], 1.13-1.37; P <=.001] and MACEs (HR, 1.13; 95% CI, 1.06-1.21; P <=.001). Increased plasma TG/HDL-C ratio was associated with more fatal events and MACEs in essential hypertensive patients.

Description

Source:

Journal of Clinical Hypertension

Publisher:

Wiley

Keywords:

Subject

Peripheral vascular disease

Citation

Endorsement

Review

Supplemented By

Referenced By

Copy Rights Note

0

Views

0

Downloads

View PlumX Details